Search Results

Responding to the Opioid Epidemic: Legal Developments and FDA's Role
This report discusses the opioid epidemic in the U.S. and the role of the Federal Food and Drug Administration (FDA) in helping end the epidemic. The report provides an overview of FDA's existing authorities, the historical context for the opioid epidemic, and the agency's current plan for combatting the opioid epidemic, concluding with an examination of the broader legal questions concerning the crisis.
Suicide, PTSD, and Substance Use Among OEF/OIF Veterans Using VA Health Care: Facts and Figures
This brief report addresses three relevant topics that affect veterans: suicide, posttraumatic stress disorder (PTSD), and substance use disorders.
The Comprehensive Addiction and Recovery Act of 2016 (S. 524): Comparison of Senate- and House-Passed Versions
This report discusses selected differences and similarities between the Senate- and House-passed versions of the Comprehensive Addiction and Recovery Act of 2016 (CARA; S. 524), which aims to address the problem of opioid addiction in the United States. The two versions of the bill differ substantially. The scope of the differences may be illustrated by their structures: The Senate bill has 28 sections organized in 8 titles, whereas the House bill has 69 sections organized in 18 titles.
Active Opioid Legislation in the House: In Brief
This report briefly summarizes opioid-related bills that were considered during "Opioid Week" (the week of May 9, 2016) The summaries in this report may be useful illustrations of the range of approaches Members of Congress have proposed to address the problem of opioid addiction.
Prescription Drug Abuse
This report examines prescription drug abuse in the United States. An estimated 6.8 million individuals currently abuse prescription drugs in the United States. Unlike policy on street drugs, federal policy on prescription drug abuse is complicated by the need to maintain access to prescription controlled substances (PCS) for legitimate medical use. The federal government has several roles in reducing prescription drug abuse.
Constitutional Analysis of Suspicionless Drug Testing Requirements for the Receipt of Governmental Benefits
This report gives an overview of the issues related to federal or state laws that condition the initial or ongoing receipt of governmental benefits on passing drug tests. These regulations are vulnerable to constitutional challenge, most often due to issues of personal privacy and Fourth Amendment protections against "unreasonable searches."
Constitutional Analysis of Suspicionless Drug Testing Requirements for the Receipt of Governmental Benefits
This report provides an overview of the Fourth Amendment in order to effectively evaluate the constitutionality of laws requiring suspicionless drug tests to receive governmental benefits. It then reviews five Supreme Court decisions that have evaluated these programs. The report concludes with a synthesis of the various factors that likely will be important to a future court's assessment of the constitutionality of these laws.
Constitutional Analysis of Suspicionless Drug Testing Requirements for the Receipt of Governmental Benefits
This report gives an overview of the issues related to federal or state laws that condition the initial or ongoing receipt of governmental benefits on passing drug tests. These regulations are vulnerable to constitutional challenge, most often due to issues of personal privacy and Fourth Amendment protections against "unreasonable searches."
Governmental Drug Testing Programs: Legal and Constitutional Developments
This report examines the current state of constitutional law on the subject of governmentally mandated drug testing in employment and of students in the public schools, which is followed by a brief review of federal drug-free workplace programs presently in effect.
The Safe and Drug-Free Schools and Communities Act: Reauthorization and Appropriations
This report discusses the approved reauthorization legislation to extend and amend the Elementary and Secondary Education Act (ESEA) and the Safe and Drug-Free Schools and Communities Act (SDFSCA).
The SUPPORT for Patients and Communities Act (P.L. 115-271): Food and Drug Administration and Controlled Substance Provisions
This report summarizes the provisions in Title III--the FDA (Food and Drug Administration) and Controlled Substance Provisions, as well as Section 4004 "Modernizing the Reporting Requirements of Biological and Biosimilar Products" in Title IV--Offsets.
Extraterritorial Application of American Criminal Law
Crime is ordinarily proscribed, tried, and punished according to the laws of the place where it occurs. American criminal law applies beyond the geographical confines of the United States, however, under certain limited circumstances. A surprising number of federal criminal statutes have extraterritorial application, but prosecutions have been few. This may be because when extraterritorial criminal jurisdiction does exist, practical and legal complications, and sometimes diplomatic considerations, may counsel against its exercise.
Extraterritorial Application of American Criminal Law
Crime is ordinarily proscribed, tried, and punished according to the laws of the place where it occurs. American criminal law applies beyond the geographical confines of the United States, however, under certain limited circumstances. A surprising number of federal criminal statutes have extraterritorial application, but prosecutions have been few. This may be because when extraterritorial criminal jurisdiction does exist, practical and legal complications, and sometimes diplomatic considerations, may counsel against its exercise.
Buprenorphine and the Opioid Crisis: A Primer for Congress
This report addresses questions policymakers may have about the effectiveness of the opioid addiction treatment drug buprenorphine, the demand for buprenorphine, and access to buprenorphine.
Opioid Treatment Programs and Related Federal Regulations
This report provides information on federal regulations regarding treatment for opioid addiction, including medication-assisted treatment (MAT), opioid treatment programs (OTPs), and DATA-waived providers (DWPs).
Increase in Illicit Fentanyl Overdose Deaths
This report discusses fentanyl, a synthetic opioid that is 50-100 times more potent than morphine. The steep increase in overdose deaths involving fentanyl is seen as a "new chapter" in the opioid epidemic. Topics covered include the rise of fentanyl overdoses, availability of fentanyl, and policy considerations.
Medical Marijuana: Review and Analysis of Federal and State Policies
This report discusses the issue facing Congress on whether to continue to support the executive branch’s prosecution of medical marijuana patients and their providers, in accordance with marijuana’s status as a Schedule I drug under the Controlled Substances Act, or whether to relax federal marijuana prohibition enough to permit the medical use of botanical cannabis products by seriously ill persons, especially in states that have created medical marijuana programs under state law.
War On Drugs: Legislation in the 108th Congress and Related Developments
This report covers significant legislative and oversight activities of the 108th Congress that concern domestic law enforcement aspects of federal anti-drug policy. It also includes an overview of significant executive branch actions and other current developments of likely interest to the congressional audience that follows this issue.
War on Drugs: Reauthorization of the Office of National Drug Control Policy
This report discusses the Office of National Drug Control Policy Reauthorization Act of 2005 , which would reauthorize ONDCP for five years, through FY2010, and authorize funding in specific annual amounts for the High Intensity Drug Trafficking Area (HIDTA) Program, the media campaign, a Southwest Border violence study, and several anti-methamphetamine initiatives.
War on Drugs: The National Youth Anti-Drug Media Campaign
This report discusses the authorization of the National Youth Anti-Drug Media Campaign, a multi-media federal program to persuade America's youth not to use drugs, which expired at the end of FY2002. H.R. 2829 (passed by the House on March 13, 2006) and S. 2560 (reported by the Senate Judiciary Committee on May 25, 2006) would reauthorize the media campaign, along with the other programs run by the Office of National Drug Control Policy (ONDCP) during FY2007.
Heroin Trafficking in the United States
This report provides an overview of heroin trafficking into and within the United States. It includes a discussion of links between the trafficking of heroin and the illicit movement of related substances such as controlled prescription drugs and synthetic drugs like fentanyl. The report also outlines existing U.S. efforts to combat heroin trafficking and possible congressional considerations going forward.
High Intensity Drug Trafficking Areas (HIDTA) Program
This report provides an overview of the High Intensity Drug Trafficking Areas (HIDTA) program, including how areas are designated as part of a HIDTA, and program coordination and funding. It also examines issues that policymakers may consider as they debate the future of the program: whether the county is still an appropriate unit of inclusion, whether the criteria remain adequate, whether the program is effective, whether its tangential effects can be measured, whether the current bounds on funds are still appropriate, and which federal entity may be best suited to administer the program.
Federal Crime Control Issues in the 111th Congress
This report aggregates various issues surrounding federal crime control into five broad themes: violent crime control, combating fraud and theft, drug control, sentencing reform, and state and local justice assistance. Within these themes, the report examines more specific issues that confronted the 111th Congress. Issues discussed under the umbrella of violent crime control include hate crimes, gangs, and gun control. Issues related to the federal government's efforts to combat fraud and theft include identity theft and organized retail crime.
Prescription Drug Monitoring Programs
This report looks at ways that prescription drug monitoring programs (PDMPs), which maintain statewide electronic databases of prescriptions dispensed for controlled substances, can help to deter prescription drug misuse.
Prescription Drug Monitoring Programs
This report looks at ways that prescription drug monitoring programs (PDMPs), which maintain statewide electronic databases of prescriptions dispensed for controlled substances, can help to deter prescription drug misuse.
Federal Domestic Illegal Drug Enforcement Efforts: Are They Working?
This report examines the federal drug enforcement data reported annually by key agencies charged with enforcing federal drug control laws. This report provides background and an overview of current federal drug control efforts and outcomes.
Federal Domestic Illegal Drug Enforcement Efforts: Are They Working?
This report examines the federal drug enforcement data reported annually by key agencies charged with enforcing federal drug control laws.
Federal Domestic Illegal Drug Enforcement Efforts: Are They Working?
This report examines the federal drug enforcement data reported annually by key agencies charged with enforcing federal drug control laws.
Methamphetamine: Legislation and Issues in the 109th Congress
This report provides a brief overview of illicit methamphetamine (MA) abuse, production, trafficking, the federal methamphetamine-specific programs, and anti-MA legislation introduced in the 109th Congress. MA abuse has implications for public health, child welfare, crime and public safety, border security, and international relations.
Marijuana: Medical and Retail -- An Abbreviated View of Selected Legal Issues
This report discusses the federal law regarding marijuana that is classified as a Schedule I Controlled Substance. The federal Controlled Substances Act (CSA) outlaws the possession, cultivation, or distribution of marijuana except for authorized research.
Marijuana: Medical and Retail -- Selected Legal Issues
This report discusses state medical marijuana laws that grants registered patients, their doctors, and providers immunity from the consequences of state law.
Marijuana: Medical and Retail-- Selected Legal Issues
This report discusses the federal Controlled Substances Act (CSA) as it pertains to marijuana. The CSA outlaws the possession, cultivation, and distribution of marijuana except for authorized research. More than 20 states have regulatory schemes that allow possession, cultivation, and distribution of marijuana for medicinal purposes. The U.S. Constitution's Supremacy Clause preempts any state law that conflicts with federal law.
2016 Rio Games: Anti-Doping Testing
This report discusses the the anti-doping testing program during the 2016 Summer Olympics. Responsibility for the rests with the International Olympic Committee (IOC). The testing period began July 24, 2016, when the Olympic village opened, and continues through August 21, 2016, the date of the closing ceremony.
Legislation Relating to the Control of Drug Abuse, 92nd Congress
This report
Federal Laws Relating to the Control of Narcotics and Other Dangerous Drugs, Enacted 1961-1985: Brief Summaries
This report contains summaries of enactments, treaties, and reorganization plans, passed from 1961 through 1985, that have some clearly indicated relationship-- either by specific reference or by virtue of legislative history--to the Federal effort to prevent drug misuse through control of the supply of narcotics and other dangerous drugs.
Federal Drug Control: President's Budget Request for Fiscal Year 1988
This report discusses the President's FY1988 budget, focusing on the $3 billion set aside for Federal programs to control or prevent the use of narcotics and other dangerous drugs. The report includes various key documents illustrating the positions taken by Congressional critics of the request as well as the Administration's defenses. Finally, for a longer term perspective, there are graphs and a table showing drug budget trends since FY 1981.
Federal Drug Control: President's Budget Request for Fiscal Year 1988
This report discusses the President's FY1988 budget, focusing on the $3 billion set aside for Federal programs to control or prevent the use of narcotics and other dangerous drugs. The report includes various key documents illustrating the positions taken by Congressional critics of the request as well as the Administration's defenses. Finally, for a longer term perspective, there are graphs and a table showing drug budget trends since FY 1981.
Control of Drug Abuse : Summary of Principal Legislative Activity in the 93rd Congress
This report collects Federal government efforts to control drug abuse in the United States.
Methadone Maintenance Treatment for Heroin Addiction
This report discusses methadone treatment centers for heroin addicts and research regarding their successes and limitations.
Drug Testing and Crime-Related Restrictions in TANF, SNAP, and Housing Assistance
Report that describes and compares the drug- and crime-related policy restrictions contained in selected federal programs that provide assistance to low-income individuals and families: the Temporary Assistance for Needy Families (TANF) block grant, the Supplemental Nutrition Assistance Program (SNAP, formerly Food Stamps), and the three primary federal housing assistance programs (the public housing program, the Section 8 Housing Choice Voucher program, and the project-based Section 8 rental assistance program).
Drug Testing and Crime-Related Restrictions in TANF, SNAP, and Housing Assistance
This report describes and compares the drug- and crime-related policy restrictions contained in selected federal programs that provide assistance to low-income individuals and families: the Temporary Assistance for Needy Families (TANF) block grant, the Supplemental Nutrition Assistance Program (SNAP, formerly Food Stamps), and the three primary federal housing assistance programs (the public housing program, the Section 8 Housing Choice Voucher program, and the project-based Section 8 rental assistance program).
Substance Abuse Prevention, Treatment, and Research Efforts in the Military
This report discusses substance abuse trends in the military, efforts by the U.S. Department of Defense (DOD) to address the opioid crisis, and the main elements of DOD's substance abuse prevention, compliance, and disciplinary policies.
Developments in the Right of Privacy: Whalen v. Roe and the Extent of the Right to Anonymity in the Doctor-Patient Relationship
This report outlines the question of privacy between doctor and patient and the potential abuse of prescription drugs without state and federal intervention.
Drug Control: International Policy and Approaches
This report discusses various U.S. international narcotics policy approaches meant to achieve two main goals: to reduce the supply of illicit narcotics flowing into the United States, and to reduce the amount of illicit narcotics cultivated, processed, and consumed worldwide.
Drug Abuse and Minority Groups in the United States: Selected References
This bibliography is a collection of published works concerning minority groups and drug abuse in the United States.
Drug Abuse in the Military: Selected References 1970-1972
This bibliography collects published works on drug abuse in the United States Military published from 1970 to 1972.
Heroin: Legalization for Medical Use
This report discusses the limited legalization of diacetylmorphine (heroin) for use in the medical treatment of intractable pain. The report attempts to present pros and cons on the issue as well as information on pending legislation. The report also provides a comparison of heroin's analgesic qualities to those of currently available and equivalent pharmaceutical alternatives.
U.S.-Mexican Security Cooperation: The Mérida Initiative and Beyond
This report begins with a brief discussion of security challenges in Mexico and Mexico's security strategy. It then provides information on congressional funding and oversight of the Mérida Initiative, with details about each of the program's four pillars. The report concludes by raising policy issues that Congress may wish to consider.
U.S.-Mexican Security Cooperation: The Mérida Initiative and Beyond
This report provides a framework for examining the current status and future prospects for U.S.- Mexican security cooperation. It begins with a brief discussion of the threat that drug trafficking and related crime and violence pose to both nations, followed by an analysis of the evolution of the Mérida Initiative. The report then provides an overview of the Peña Nieto government's security strategy and how it is affecting the Mérida Initiative. The report then examines key aspects of the current U.S.-Mexican security strategy and concludes by raising policy issues that may affect bilateral efforts.
U.S.-Mexican Security Cooperation: The Mérida Initiative and Beyond
Increasing violence perpetrated by drug trafficking organizations and other criminal groups is threatening citizen security and governance in Mexico. Escalating violence has increased U.S. concerns about stability in Mexico, a key political and economic ally, and about the possibility of violence spilling over into the United States. In recent years, U.S.-Mexican security cooperation has increased significantly, largely as a result of the development and implementation of the Mérida Initiative, a counterdrug and anticrime assistance package for Mexico and Central America that was first proposed in October 2007. This report looks at the funding and Congressional oversight for this Initiative.
Back to Top of Screen